| Useful Advices |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Sales Training > Speed Kills - Selling Too Quickly Can Cost The Sale |
|
Useful Advices - Speed Kills - Selling Too Quickly Can Cost The Sale
In a time when more and more people are seeking instant gratification and seem to have less and l According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product ess time and patience, many salespeople are trying to rush their sale cycle. In my experience and ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in opinion, they do so at their own peril. Speed, the attempt to rush the process, can kill the sal lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. e. This is why. The art of selling is the art of 'establishing trust' along wit here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe h 'building value' to the point that it exceeds price and 'effective pro d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro lem solving'. Each of those steps takes time and to reduce efforts in any of those areas ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc will often result in a lost sale. Establishing trust is extremely unlikely if the prospect feel easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi s that he or she is being rushed or pressured for the salesperson's benefit or convenience. Part nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically of the process of developing trust is careful and thorough qualification. How will a salesperson and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ properly problem solve without that information. Prospects are much more likely to spend their h ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi rd earned money with someone they believe is working for them rather than working solely for them ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a selves. In order to reduce the importance of price in the customer's mind and remove price as an dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod obstacle, it is always necessary to build sufficient value for the prospect. This is done by lay cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin ering benefit upon benefit. This can rarely be done quickly if the salesperson wants to be sure t tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen hat the customer understands the full value being revealed to him or her. The salesperson is wis t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel to understand that the prospect begins the buying experience with a perceived need or with a pro ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust blem of some sort to be solved. Demonstrating that the offering being made is the best solution t y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products o the prospect's 'problem' will result in a closed sale. Take sufficient time time to ensure that . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de at least these three areas are handled well with all prospects. Speeding will cost you a lot of elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip money on the road. Be aware of just how much money it can cost you in lost selling opportunities tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Associations Deliberating the Conference Conundrum Ceramic and Pottery Defects 2: Defects from Raw Materials and Batching Errors The 12 Reasons Why Most Ads Fall Flat On Their Face Costing A Fortune Instead Of Making You Money
|